GELSOMINO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 4.354
AS - Asia 2.163
EU - Europa 2.147
SA - Sud America 302
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 9.034
Nazione #
US - Stati Uniti d'America 4.244
IT - Italia 719
SG - Singapore 654
CN - Cina 590
GB - Regno Unito 390
VN - Vietnam 248
HK - Hong Kong 233
BR - Brasile 221
FI - Finlandia 171
SE - Svezia 159
DE - Germania 150
FR - Francia 113
RU - Federazione Russa 113
BD - Bangladesh 88
UA - Ucraina 73
IE - Irlanda 64
IN - India 61
KR - Corea 59
CA - Canada 58
ID - Indonesia 56
TR - Turchia 36
MX - Messico 34
AR - Argentina 31
LT - Lituania 30
JP - Giappone 27
BG - Bulgaria 26
ZA - Sudafrica 24
ES - Italia 21
AT - Austria 20
NL - Olanda 20
PL - Polonia 20
IQ - Iraq 16
EC - Ecuador 14
VE - Venezuela 13
CZ - Repubblica Ceca 12
AE - Emirati Arabi Uniti 11
BE - Belgio 11
PK - Pakistan 10
UZ - Uzbekistan 10
CH - Svizzera 9
PY - Paraguay 8
AZ - Azerbaigian 7
JO - Giordania 7
TN - Tunisia 7
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
IR - Iran 4
JM - Giamaica 4
MA - Marocco 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
CO - Colombia 3
CY - Cipro 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
NG - Nigeria 3
PA - Panama 3
PT - Portogallo 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LB - Libano 2
OM - Oman 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AN - Antille olandesi 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GT - Guatemala 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 9.027
Città #
Ashburn 568
Santa Clara 435
Singapore 407
Fairfield 395
Chandler 254
San Jose 238
Hong Kong 230
Woodbridge 196
Southend 182
Hefei 160
Helsinki 149
Seattle 149
Houston 147
Wilmington 133
Cambridge 127
Nyköping 116
Council Bluffs 101
London 97
New York 97
Beijing 91
Ho Chi Minh City 83
Los Angeles 83
Shanghai 79
Dearborn 73
Ann Arbor 71
Dublin 61
Seoul 58
Hanoi 50
Milan 47
Jacksonville 46
San Diego 46
Chicago 45
Jakarta 45
Modena 45
Lauterbourg 36
The Dalles 32
Munich 30
Buffalo 28
Princeton 27
Dong Ket 26
Bologna 25
Moscow 25
Orem 25
Rome 25
Sofia 25
São Paulo 24
Tokyo 24
Atlanta 22
Izmir 21
Salt Lake City 19
Bremen 18
Dallas 18
Florence 18
Johannesburg 18
Eugene 16
Ottawa 16
Warsaw 16
Phoenix 14
Toronto 14
Brooklyn 13
Falls Church 13
Frankfurt am Main 13
Poplar 13
Siena 13
Turku 13
Naples 12
Reggio Emilia 12
Stockholm 12
Ferrara 11
Kent 11
Manchester 11
Mexico City 11
Montreal 11
Redwood City 11
Brussels 10
Denver 10
Des Moines 10
Parma 10
Redondo Beach 10
Brno 9
Düsseldorf 9
Hyderabad 9
Nuremberg 9
Vienna 9
Baghdad 8
Boston 8
Charlotte 8
Chennai 8
Guangzhou 8
Haiphong 8
Tampa 8
Washington 8
Amsterdam 7
Boardman 7
Brasília 7
Da Nang 7
Elk Grove Village 7
Mumbai 7
Napoli 7
Palermo 7
Totale 6.061
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 610
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) 440
The evolving role of microsatellite instability in colorectal cancer: A review 348
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 343
Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion 338
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 319
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 315
Il trattamento di prima e seconda linea nel carcinoma gastrico 309
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 286
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 278
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 273
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 261
Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: Results from the ITACa randomized clinical trial 260
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs) 255
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial 246
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 245
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 241
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC) 239
Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study 237
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. 233
BRAF-mutated colorectal cancer: Clinical and molecular insights 224
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy 222
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 220
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 217
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 210
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST 206
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 192
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 181
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 172
Hereditary Micro‑Satellite Instable cancers associated with Lynch Syndrome: predictive biomarkers and novel immuno-therapeutic approaches 169
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis 144
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition 143
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus 141
Homologous recombination deficiency in pancreatic neuroendocrine tumors 134
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 132
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience 124
Spontaneous Regression of an Inflammatory Myofibroblastic Tumor: A Case Report and a Review of the Literature 105
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study 98
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center. 7
Totale 9.117
Categoria #
all - tutte 34.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 0 57
2021/2022633 49 44 30 19 32 57 18 43 60 88 137 56
2022/2023723 80 94 55 76 82 95 13 56 103 22 27 20
2023/2024499 7 26 36 70 66 54 52 61 5 10 54 58
2024/20251.674 56 15 27 108 288 232 144 103 198 91 134 278
2025/20263.488 272 126 216 395 513 238 465 190 282 353 283 155
Totale 9.117